THE EFFECT OF ADDING INTERFERON (RIFN(ALPHA-2)) OR HIGH-DOSE CYCLOPHOSPHAMIDE TO VBMCP TO TREAT MULTIPLE-MYELOMA - RESULTS FROM AN ECOG PHASE-III TRIAL
Mm. Oken et al., THE EFFECT OF ADDING INTERFERON (RIFN(ALPHA-2)) OR HIGH-DOSE CYCLOPHOSPHAMIDE TO VBMCP TO TREAT MULTIPLE-MYELOMA - RESULTS FROM AN ECOG PHASE-III TRIAL, Blood, 86(10), 1995, pp. 1749-1749